MAGE-C1/CT7 and MAGE-C2/CT10 are frequently expressed in multiple myeloma and can be explored in combined immunotherapy for this malignancy

被引：25
作者：
de Carvalho, Fabricio [1 ]
Alves, Veruska L. F. [1 ]
Braga, Walter M. T. [1 ]
Xavier, Celso V., Jr. [1 ]
Colleoni, Gisele W. B. [1 ]
机构：
[1] Univ Fed Sao Paulo UNIFESP EPM, Disciplina Hematol & Hemoterapia, BR-04023900 Sao Paulo, Brazil
来源：
CANCER IMMUNOLOGY IMMUNOTHERAPY | 2013年 / 62卷 / 01期
关键词：
MAGE-C1/CT7; MAGE-C2/CT10; Cancer/testis antigen; Conventional RT-PCR; Monoclonal gammopathies; CANCER/TESTIS ANTIGENS; MAGE FAMILY; IDENTIFICATION; GENE; CT7;
D O I：
10.1007/s00262-012-1376-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The exact function of MAGE-C1/CT7 and MAGE-C2/CT10 is not yet understood in multiple myeloma (MM). However, the homologs MAGE-C1/CT7 and MAGE-C2/CT10 genes encode highly immunogeneic cancer/testis antigens (CTAs) and can be potential targets for T cell-based immunotherapy. MAGE-C1/CT7 and MAGE-C2/CT10 mRNA expression were investigated in MM patients, solitary plasmacytomas, monoclonal gammopathies of undetermined significance (MGUS) and bone marrow (BM) aspirates from healthy donors by RT-PCR. MAGE-C1/CT7 and MAGE-C1/CT10 were expressed in 67 and 59 % of the 46 MM analyzed patients. At least one of the genes was expressed in 76 % of MM cases. Solitary plasmacytoma also showed MAGE-C1/CT7 and MAGE-C2/CT10 expression. MAGE-C1/CT7 and MAGE-C2/CT10 were not expressed in normal BM samples, showing restricted expression of these CTA genes in MM, solitary plasmacytoma and MGUS. In the present study, we found high expression of the homologs MAGE-C1/CT7 and MAGE-C2/CT10 in monoclonal gammopathies and speculate whether these genes might represent a valuable therapeutic option for myeloma, in particular for combined immunotherapy.
引用
收藏
页码：191 / 195
页数：5
相关论文
共 28 条
[1]   New Insights into Therapeutic Targets in Myeloma [J].
Anderson, Kenneth C. .
HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, :184-190
[2]   Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma [J].
Anderson, Larry D., Jr. ;
Cook, Danielle R. ;
Yamamoto, Tori N. ;
Berger, Carolina ;
Maloney, David G. ;
Riddell, Stanley R. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (07) :985-997
[3]  
Andrade Valeria C C, 2008, Cancer Immun, V8, P2
[4]   Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells [J].
Atanackovic, Djordje ;
Hildebrandt, York ;
Jadczak, Adam ;
Cao, Yanran ;
Luetkens, Tim ;
Meyer, Sabrina ;
Kobold, Sebastian ;
Bartels, Katrin ;
Pabst, Caroline ;
Lajmi, Nesrine ;
Gordic, Maja ;
Stah, Tanja ;
Zander, Axel R. ;
Bokemeyer, Carsten ;
Kroeger, Nicolaus .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (05) :785-793
[5]   Longitudinal Analysis and Prognostic Effect of Cancer-Testis Antigen Expression in Multiple Myeloma [J].
Atanackovic, Djordje ;
Luetkens, Tim ;
Hildebrandt, York ;
Arfsten, Julia ;
Bartels, Katrin ;
Horn, Christiane ;
Stahl, Tanja ;
Cao, Yanran ;
Zander, Axel R. ;
Bokemeyer, Carsten ;
Kroeger, Nicolaus .
CLINICAL CANCER RESEARCH, 2009, 15 (04) :1343-1352
[6]   Cancer/testis (CT) antigens: Potential targets for immunotherapy [J].
Caballero, Otavia L. ;
Chen, Yao-Tseng .
CANCER SCIENCE, 2009, 100 (11) :2014-2021
[7]   Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library [J].
Chen, YT ;
Güre, AO ;
Tsang, S ;
Stockert, E ;
Jäger, E ;
Knuth, A ;
Old, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) :6919-6923
[8]   Expression of MAGE-C1/CT7 and MAGE-C2/CT10 Predicts Lymph Node Metastasis in Melanoma Patients [J].
Curioni-Fontecedro, Alessandra ;
Nuber, Natko ;
Mihic-Probst, Daniela ;
Seifert, Burkhardt ;
Soldini, Davide ;
Dummer, Reinhard ;
Knuth, Alexander ;
van den Broek, Maries ;
Moch, Holger .
PLOS ONE, 2011, 6 (06)
[9]   Cancer/Testis Antigen MAGE-C1/CT7: New Target for Multiple Myeloma Therapy [J].
de Carvalho, Fabricio ;
Vettore, Andre L. ;
Colleoni, Gisele W. B. .
CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,
[10]   Targeting MAGE-C1/CT7 Expression Increases Cell Sensitivity to the Proteasome Inhibitor Bortezomib in Multiple Myeloma Cell Lines [J].
de Carvalho, Fabricio ;
Costa, Erico T. ;
Camargo, Anamaria A. ;
Gregorio, Juliana C. ;
Masotti, Cibele ;
Andrade, Valeria C. C. ;
Strauss, Bryan E. ;
Caballero, Otavia L. ;
Atanackovic, Djordje ;
Colleoni, Gisele W. B. .
PLOS ONE, 2011, 6 (11)
123